Huntington's Arm to Divest Corporate Trust Business, Shares Up 3.05% — Positive
HBAN Zacks Investment Research — June 09, 2025HBAN rises 3.05% as it announces an agreement to offload its corporate trust business to AITC, sharpening its focus on core banking services.

Coinbase's Transaction Fees Improve: Will it Accelerate Growth? — Neutral
COIN Zacks Investment Research — June 09, 2025Coinbase Global generates the bulk of its revenues from transaction fees, the largest but most volatile income source.

BRK.B's Insurance Business Grows Steadily: Can it Accelerate Growth? — Positive
BRK-A BRK-B Zacks Investment Research — June 09, 2025BRK.'s insurance arm drives steady growth with rising float and strong underwriting, even as EPS estimates for 2025 dip.

United Airlines Stock Up 4.83% on Friday's Trading: Here's Why — Positive
UAL Zacks Investment Research — June 09, 2025The partnership aims to elevate the traveling experience of UAL customers by offering Spotify's in-flight streaming services for free.

Are You Looking for a Top Momentum Pick? Why Astera Labs, Inc. (ALAB) is a Great Choice — Positive
ALAB Zacks Investment Research — June 09, 2025Does Astera Labs, Inc. (ALAB) have what it takes to be a top stock pick for momentum investors? Let's find out.

What Makes Peakstone Realty Trust (PKST) a New Strong Buy Stock — Positive
PKST Zacks Investment Research — June 09, 2025Peakstone Realty Trust (PKST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ACNB (ACNB) Upgraded to Strong Buy: Here's Why — Positive
ACNB Zacks Investment Research — June 09, 2025ACNB (ACNB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

What Makes Tenet Healthcare (THC) a Strong Momentum Stock: Buy Now? — Positive
THC Zacks Investment Research — June 09, 2025Does Tenet Healthcare (THC) have what it takes to be a top stock pick for momentum investors? Let's find out.

DLocal (DLO) Upgraded to Buy: What Does It Mean for the Stock? — Positive
DLO Zacks Investment Research — June 09, 2025DLocal (DLO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Synovus (SNV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here's Why Intuit (INTU) is a Great Momentum Stock to Buy — Positive
INTU Zacks Investment Research — June 09, 2025Does Intuit (INTU) have what it takes to be a top stock pick for momentum investors? Let's find out.

Trupanion (TRUP) Upgraded to Buy: What Does It Mean for the Stock? — Positive
TRUP Zacks Investment Research — June 09, 2025Trupanion (TRUP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

What Makes BlackLine (BL) a Strong Momentum Stock: Buy Now? — Positive
BL Zacks Investment Research — June 09, 2025Does BlackLine (BL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Canadian Imperial Bank (CM) Is Up 1.31% in One Week: What You Should Know — Positive
CM Zacks Investment Research — June 09, 2025Does Canadian Imperial Bank (CM) have what it takes to be a top stock pick for momentum investors? Let's find out.

Don't Like The Price? Don't Exit: Palantir Remains A Buy In My Books — Positive
PLTR Seeking Alpha — June 09, 2025I maintain my long-term buy on Palantir Technologies Inc., but I advise investors to be cautious at current levels due to potential near-term volatility. Palantir's fundamentals remain solid, driven by expanding government contracts, defense deals, and new partnerships in healthcare and finance. Valuation is stretched, leaving little room for execution errors.

Contact Levi & Korsinsky by July 15, 2025 to Join Class Action Against Krispy Kreme, Inc. (DNUT) — Neutral
DNUT Accesswire — June 09, 2025NEW YORK, NY / ACCESS Newswire / June 9, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=152312&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

Investigation Opened on Behalf of Rocket Pharmaceuticals, Inc. (RCKT) Shareholders - Contact Levi & Korsinsky — Neutral
RCKT Accesswire — June 09, 2025NEW YORK, NY / ACCESS Newswire / June 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rocket Pharmaceuticals, Inc. ("Rocket Pharmaceuticals, Inc.") (NASDAQ:RCKT) concerning possible violations of federal securities laws. Rocket issued a press release on May 27, 2025, "announcing an update related to RP-A501, its investigational gene therapy for Danon disease.

Today's Big 3 shows a lot of diversity between industries, though Kenny Polcari notes all have seen significant moves that can ignite further volatility. Kenny talks about why L3Harris (LHX) is in an industry investors "should be concerned about," CrowdStrike's (CRWD) support as it approaches overbought territory, and Groupon's (GRPN) big billings growth.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN — Neutral
BHVN Accesswire — June 09, 2025NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. ("Biohaven" or the "Company") (NYSE:BHVN).

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of New Fortress Energy Inc. - NFE — Neutral
NFE Accesswire — June 09, 2025NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of New Fortress Energy Inc. ("New Fortress" or the "Company") (NASDAQ:NFE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
